> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# License for Mass Spectrometry for Covid, Other Uses
- URL: https://www.fdaweb.com/license-for-mass-spectrometry-for-covid-other-uses/
- Published: 2020-11-12T12:00:00.000Z
- Updated: 2026-09-14T16:36:17.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148071

*Federal Register* notice: FDA is contemplating the grant of an exclusive patent license to Advion, Inc. (Ithaca, NY) for a government-owned patent for “Direct Impact Ionization Mass Spectrometry.” The license is limited to the manufacture and commercialization of a field-deployable mass spectrometer diagnostic for the rapid detection of SARS, SARS-CoV-2 and other viruses, bacteria and bacterial serovar, and drug impurities. FDA is seeking comments on the patent license. To view the notice, click [here](https://public-inspection.federalregister.gov/2020-25142.pdf?ref=fdaweb.com).